3RG-27218-25155
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 210 / MD
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FUC-13977-62135
Child or adolescent in my care · Male · 2022-11-23
5JG-20506-09066
Child or adolescent in my care · Female · 2022-11-23
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Muscle or body achesAdult check-in
- 2020-12-26
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Fever · ChillsAdult check-in
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Pharyngeal paraesthesia — Feeling: Fair · Fever · Chills · Be unable to workFree text: Cough, tingling in the throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-28
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: Fair · Be unable to workFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
-
2020-12-30
Survey response — day 7, dose 1MedDRA: Cough — Feeling: GoodFree text: Mild coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · Fever · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-18
- 2021-01-23
- 2021-01-28
- 2021-02-04
- 2021-02-12
- 2021-02-23
- 2021-04-15
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-04
- 2021-10-07
- 2021-10-09
- 2021-10-16
- 2021-11-08
- 2021-11-13
- 2022-01-01
- 2022-04-02
- 2022-10-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-28 | priority 2/3 | |
| 2020-12-29 | priority 2/3 | |
| 2021-01-13 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Cough, tingling in the throat
Systemic reaction (other): Cough
Release 1 — day 7, dose 1
Systemic reaction (other): Mild cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Pharyngeal paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release